Back to Search Start Over

Effects of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, and free omega-3 carboxylic acids on liver steatosis and hepatocyte damage biomarkers in Type 2 diabetes patients with non-alcoholic fatty liver disease

Authors :
Oscarsson, Jan
Lundkvist, Per
Jansson, Per-Anders E.
Johansson, Lars
Kvarnström, Mats
Moris, Linda
Risérus, Ulf
Lind, Lars
Eriksson, Jan W.
Oscarsson, Jan
Lundkvist, Per
Jansson, Per-Anders E.
Johansson, Lars
Kvarnström, Mats
Moris, Linda
Risérus, Ulf
Lind, Lars
Eriksson, Jan W.
Publication Year :
2016

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1235202993
Document Type :
Electronic Resource

Tools

Authors Abstract Subjects Details